SS-31 (Elamipretide) · Research brief

First Time Buying SS-31 — What Research Teams Need to Know

Q: What is SS-31 and how does it work in mitochondria?

SS-31 (Elamipretide) is an aromatic-cationic tetrapeptide with the sequence D-Arg-Dmt-Lys-Phe-NH2 that selectively binds to cardiolipin, a phospholipid found almost exclusively on the inner mitochondrial membrane. Its positively charged D-Arg residue and hydrophobic aromatic residues allow it to penetrate lipid bilayers and concentrate in mitochondria at ratios exceeding 5,000:1 relative to the cytosol. Once localized, SS-31 prevents cardiolipin peroxidation, stabilizes cristae structure, and maintains electron transport chain efficiency — reducing reactive oxygen species production and preserving ATP synthesis even under oxidative stress or ischemic conditions.

Q: How pure should SS-31 be for mechanistic research studies?

Research-grade SS-31 should be ≥98% pure as determined by analytical HPLC, with sequence confirmed by mass spectrometry. Purity below 98% means 2% or more of the material is truncated peptides, oxidized analogs, or synthesis byproducts that contribute nothing to cardiolipin binding — introducing systematic error in dose-response studies where precise molar concentrations determine outcomes. For preliminary feasibility work, 95–96% purity may be acceptable, but publication-quality mechanistic studies require ≥98% purity with documented chromatograms to ensure reproducibility across experimental replicates and study cohorts.

Q: Can I store reconstituted SS-31 in the refrigerator for multiple weeks?

No — reconstituted SS-31 stored at 4°C shows measurable oxidation of the dimethyltyrosine (Dmt) residue within 7–10 days, which progressively reduces cardiolipin binding affinity even though the solution remains clear and soluble. For multi-week studies, prepare frozen aliquots in your final working concentration and store them at −80°C, where SS-31 maintains >95% purity for at least 6 months. Thaw one aliquot per experiment day rather than diluting repeatedly from a single refrigerated stock, as this approach eliminates freeze-thaw degradation and prevents cumulative oxidation that occurs in refrigerated aqueous solutions.

Q: What happens if I use SS-31 that has been stored improperly or shows signs of degradation?

Degraded SS-31 retains solubility and appears visually normal but loses cardiolipin binding affinity due to oxidation of the dimethyltyrosine residue or aggregation from repeated freeze-thaw cycles. In experimental systems, this manifests as null results or inconsistent dose-response relationships — the peptide is present at the calculated concentration but functionally inactive. There is no simple way to test for degradation without re-running HPLC analysis, which is why prevention through proper storage (−80°C for aliquots, −20°C for lyophilized powder) and cold-chain shipping is critical. If you suspect degradation, do not attempt to salvage the batch — request replacement from the supplier and document the storage or handling failure that caused the issue.

Q: Why does SS-31 require the D-Arg residue instead of standard L-arginine?

The D-Arg (D-arginine) residue at the N-terminus of SS-31 provides resistance to proteolytic degradation by aminopeptidases, which specifically cleave L-amino acids but cannot process D-amino acid residues efficiently. This modification extends SS-31’s half-life in biological systems and maintains its structural integrity long enough to reach and bind cardiolipin in mitochondria. If L-arginine were used instead, the tetrapeptide would be rapidly degraded by proteases in serum, cell culture media, or tissue homogenates — eliminating its therapeutic or research effect before mitochondrial localization could occur. This is why sequence verification by mass spectrometry is essential for first time buying SS-31, as synthesis errors substituting L-Arg for D-Arg produce a peptide with similar molecular weight but no functional stability.

Q: Can I buy SS-31 in pre-made solutions, or does it always come as lyophilized powder?

Most research-grade SS-31 is supplied as lyophilized powder because this form provides maximum stability during storage and shipping, with shelf life exceeding 12 months at −20°C. Pre-made aqueous solutions are uncommon because reconstituted SS-31 begins oxidizing within 7–10 days at 4°C, making long-term storage impractical. Some suppliers offer custom formulation services where SS-31 is reconstituted in specific buffers, pH, or concentrations immediately before shipping for time-sensitive experiments or high-throughput applications. If your experimental design requires pre-formulated SS-31, verify whether the supplier offers this service and confirm the solution will be prepared fresh within 48 hours of shipment — not drawn from pre-made inventory that has been stored for weeks.

Real Peptides Research TeamEditorial

Updated April 1, 202613 min read

60 WORDS

Short answer

Key takeaways

SS-31 (Elamipretide) is an aromatic-cationic tetrapeptide that binds cardiolipin in the inner mitochondrial membrane, stabilizing cristae structure and preventing oxidative damage. Its mechanism requires exact sequence fidelity and structural integrity.
Research-grade SS-31 should be ≥98% pure by HPLC, with sequence confirmed by mass spectrometry and endotoxin content <1 EU/mg for cell culture or in vivo applications.
Cold-chain integrity from synthesis through shipping is critical. Temperature excursions above 25°C promote Dmt oxidation and aggregation, which eliminate mitochondrial targeting capacity even when purity by weight appears acceptable.
Reconstitute SS-31 in sterile water or PBS at pH 7.0–7.4, aliquot into single-use volumes, and store at −80°C to prevent freeze-thaw degradation. Reconstituted solutions stored at 4°C lose activity within 7–10 days.
Small-batch synthesis and on-demand preparation reduce cumulative thermal and oxidative exposure compared to suppliers shipping from long-term inventory, directly improving peptide stability and study reproducibility.
First time buying SS-31 requires verification of HPLC chromatograms, mass spectrometry sequence data, and temperature monitoring documentation. Suppliers unable to provide these documents do not meet research-grade standards.

Fewer than 30% of research-grade peptide purchases include third-party purity verification. And for SS-31 (Elamipretide), that gap between specification and reality can invalidate an entire study protocol. Research published in the Journal of Biological Chemistry identified that even minor oxidation of SS-31's aromatic-cationic tetrapeptide structure eliminates its cardiolipin binding affinity, the mechanism through which the compound stabilizes mitochondrial cristae and reduces reactive oxygen species production. The difference between effective SS-31 and degraded product isn't visible. It's molecular, and it happens during synthesis, storage, or shipping if protocols aren't followed precisely.

We've worked with research institutions across cellular metabolism, ischemia-reperfusion injury, and neurodegenerative disease models. The single most common variable that separates reproducible SS-31 results from inconsistent outcomes is procurement discipline. Specifically, knowing what to verify before the compound ever reaches your cold storage.

What is SS-31, and why does procurement quality matter more than for standard peptides?

SS-31 (Elamipretide, also known as Bendavia or MTP-131) is a mitochondria-targeting aromatic-cationic tetrapeptide with the sequence D-Arg-Dmt-Lys-Phe-NH2 that selectively binds to cardiolipin on the inner mitochondrial membrane. Unlike cytosolic peptides, SS-31 operates at the site of oxidative phosphorylation. Meaning its therapeutic or research effect depends entirely on structural integrity at the molecular level. Oxidation, aggregation, or sequence errors that might produce 'close enough' results with other compounds completely eliminate SS-31's mitochondrial targeting capacity. The rest of this article covers what that means for first-time procurement: how to verify purity, what storage and reconstitution protocols prevent degradation, and which supplier practices separate research-grade SS-31 from compounds that look identical on a spec sheet but fail in application.

Understanding SS-31's Mechanism and Why Peptide Quality Determines Study Outcomes

SS-31 doesn't work through receptor binding or enzyme inhibition like most pharmacological compounds. It works through electrostatic and hydrophobic interaction with cardiolipin, a phospholipid found almost exclusively in the inner mitochondrial membrane. Cardiolipin is essential for cristae structure and optimal function of the electron transport chain complexes, particularly cytochrome c oxidase (Complex IV). When mitochondria experience oxidative stress, ischemia, or age-related dysfunction, cardiolipin becomes peroxidized. Leading to cristae disorganization, cytochrome c release, and impaired ATP synthesis.

SS-31's D-Arg residue carries a positive charge, while the dimethyltyrosine (Dmt) and phenylalanine residues provide aromatic hydrophobicity. This combination allows SS-31 to penetrate lipid bilayers and concentrate in mitochondria at ratios exceeding 5,000:1 relative to the cytosol, independent of membrane potential. Once localized, SS-31 binds to cardiolipin and prevents its oxidation. Stabilizing cristae architecture and maintaining electron transport chain efficiency even under pathological conditions. Preclinical studies in ischemia-reperfusion models published in Cardiovascular Research demonstrated that SS-31 reduced infarct size by 40–50% when administered during reperfusion, an effect that disappeared entirely when the peptide was pre-oxidized or stored improperly before administration.

This mechanism explains why peptide purity matters more for SS-31 than for many other research compounds. A 95% pure batch means 5% of the material is something other than the correct sequence. And if that 5% includes oxidized Dmt residues, aggregated peptide, or truncated sequences missing the critical Phe residue, the effective concentration of functional SS-31 in your solution may be significantly lower than calculated. For dose-response studies, receptor saturation assays, or any work requiring precise molar concentrations, even small purity gaps produce large variability. Real Peptides addresses this through small-batch synthesis with high-performance liquid chromatography (HPLC) verification for every lot, ensuring the SS-31 shipped to research labs matches the structure required for cardiolipin binding. Not just a molecular weight approximation.

What to Verify Before Your First SS-31 Purchase

When evaluating suppliers for first time buying SS-31, three specifications separate research-grade material from compounds that meet only minimum commercial standards: purity by HPLC, sequence confirmation by mass spectrometry, and cold-chain documentation. Each serves a different quality control function, and skipping any one introduces a variable your study protocol can't account for.

Purity by HPLC quantifies what percentage of the lyophilized powder is the intended peptide versus impurities. Truncated sequences, deletion peptides, or residual synthesis reagents. For SS-31, target purity should be ≥98% as determined by analytical HPLC with UV detection at 220nm. Suppliers offering 'research grade' peptides at 90–95% purity are not selling defective product. They're selling material suitable for preliminary screening, not dose-dependent mechanistic studies. The difference matters because SS-31's mitochondrial uptake is saturable: if you calculate a 10 μM working concentration but 8% of your material is inactive, your true functional concentration is closer to 9.2 μM, and that 0.8 μM gap compounds across replicates and experimental cohorts.

Sequence confirmation by mass spectrometry verifies that the amino acid sequence matches D-Arg-Dmt-Lys-Phe-NH2 exactly. Not a closely related analog with substituted residues. This matters because synthesis errors that swap L-Arg for D-Arg or replace Dmt with standard tyrosine produce a peptide with nearly identical molecular weight but completely different mitochondrial targeting properties. Mass spec analysis, particularly when paired with tandem MS/MS fragmentation, confirms both the sequence and the presence of the C-terminal amide group (-NH2), which stabilizes SS-31 against proteolytic degradation in biological systems. We provide mass spectrometry data with every batch of SS-31 Elamipretide shipped, so research teams can verify sequence fidelity before reconstitution.

Cold-chain documentation tracks the temperature history of the peptide from synthesis through shipping. Lyophilized SS-31 is stable at −20°C for months, but exposure to temperatures above 25°C. Even for 24–48 hours during shipping. Accelerates oxidation of the Dmt residue and promotes aggregation through intermolecular disulfide formation if any free cysteine contaminants are present. Suppliers using cold packs without temperature loggers cannot verify that your shipment remained below the thermal degradation threshold. Real Peptides ships all mitochondria-targeting peptides including SS-31 with insulated packaging and temperature monitoring, and our small-batch synthesis model means peptides are produced on demand rather than stored in inventory for months before fulfillment. Reducing cumulative thermal exposure before the compound ever reaches your lab.

One additional specification often overlooked by first-time buyers: endotoxin content. If your SS-31 research involves cell culture or in vivo models, lipopolysaccharide contamination from bacterial synthesis systems can trigger inflammatory responses independent of the peptide's mitochondrial effects. A confounding variable that's invisible until you run your controls. Research-grade SS-31 should include endotoxin testing with results <1 EU/mg, particularly for work involving immune cells, ischemia models, or any system where inflammatory signaling is a measured outcome.

Reconstitution, Storage, and Handling Protocols That Preserve SS-31 Activity

Once you receive SS-31, the next failure point is reconstitution and storage. Unlike larger proteins, SS-31's tetrapeptide structure makes it highly soluble in aqueous solutions. But that same solubility means it's vulnerable to concentration-dependent aggregation, pH-induced oxidation, and freeze-thaw degradation if handled incorrectly.

Reconstitution solvent choice determines stability and shelf life of your working stock. SS-31 is most stable in sterile water or phosphate-buffered saline (PBS) at pH 7.0–7.4. Avoid reconstituting in DMSO unless your experimental design requires it. DMSO can promote Dmt oxidation over time, particularly at concentrations above 10% v/v. For experiments requiring DMSO as a vehicle, prepare a concentrated stock in sterile water first, then dilute into DMSO-containing buffer immediately before use. We recommend reconstituting SS-31 at 1–10 mM in sterile water or PBS, aliquoting into single-use volumes, and storing at −80°C until needed. This approach eliminates repeated freeze-thaw cycles, which cause aggregation and reduce effective concentration by 10–15% per cycle in our stability testing.

Storage temperature and duration depend on whether the peptide is lyophilized or reconstituted. Lyophilized SS-31 stored at −20°C in a desiccated environment remains stable for at least 12 months based on HPLC re-analysis. Once reconstituted, stability drops: aqueous solutions stored at 4°C show measurable oxidation within 7–10 days, while aliquots stored at −80°C maintain >95% purity for at least 6 months. Never store reconstituted SS-31 at room temperature for more than 24 hours. Oxidation of the Dmt residue accelerates at higher temperatures, and while the peptide may still appear clear and soluble, its cardiolipin binding affinity declines progressively. For labs running multi-week studies, prepare frozen aliquots in your final working concentration and thaw one aliquot per experiment day rather than diluting from a single refrigerated stock.

Handling and preparation tips that matter: always reconstitute SS-31 gently. Vigorous vortexing can shear tetrapeptide structures and promote aggregation. Add solvent to the lyophilized peptide and allow it to dissolve passively for 2–3 minutes, then swirl gently to mix. If working with concentrations above 5 mM, consider brief sonication (10–15 seconds in a bath sonicator) to ensure complete dissolution without mechanical stress. Filter sterilize solutions through a 0.22 μm syringe filter if you're preparing stocks for cell culture work, but do this only once. Repeated filtration can result in peptide loss through membrane adsorption, particularly at low concentrations. In our experience preparing SS-31 for hundreds of research applications, the single most common protocol error is using the same stock solution for more than two weeks at 4°C. Stability data consistently shows that oxidation byproducts accumulate even in refrigerated storage, and those byproducts don't interfere with UV absorbance measurements, meaning your concentration calculations will appear correct while your functional activity declines.

For labs integrating SS-31 into broader mitochondrial research protocols, consider pairing it with complementary compounds from our catalog: MOTS-C Peptide for mitochondrial biogenesis studies, NAD+ 100mg for NADH/NAD+ redox balance work, or Epithalon Peptide for telomere-mitochondria interaction models. Each compound requires its own handling protocols, but the same quality standards. Verified purity, confirmed sequence, and cold-chain integrity. Apply across our entire line.

First Time Buying SS-31: Supplier Practices and Research-Grade Standards Comparison

Not all peptide suppliers operate under the same synthesis and quality control standards, and for first time buying SS-31, those differences translate directly into reproducibility. The table below contrasts key supplier practices that determine whether you receive functional research-grade SS-31 or a compound that meets only basic commercial specifications.

Supplier Practice	Research-Grade Standard (Required)	Commercial-Grade Standard (Insufficient for Mechanistic Studies)	Bottom Line Impact on SS-31 Research
Purity Verification	HPLC analysis with chromatogram provided per lot, ≥98% purity	Certificate of analysis with listed purity, no chromatogram, 90–95% purity	5–10% impurity can skew dose-response curves, particularly in saturation studies where mitochondrial uptake is concentration-dependent
Sequence Confirmation	Mass spectrometry with fragmentation data confirming D-Arg, Dmt, and C-terminal amide	Molecular weight confirmation only, no fragmentation	Synthesis errors substituting L-Arg or standard Tyr produce similar molecular weight but eliminate mitochondrial targeting
Synthesis Method	Small-batch solid-phase peptide synthesis with immediate lyophilization	Large-batch synthesis with extended storage before fulfillment	Small-batch synthesis reduces cumulative thermal and oxidative exposure before shipping
Cold-Chain Handling	Shipped with insulated packaging and temperature monitoring, stored at −20°C continuously	Shipped with cold packs, no temperature verification	Temperature excursions above 25°C promote Dmt oxidation and aggregation. Effects that are invisible until functional assays fail
Endotoxin Testing	LAL assay with result <1 EU/mg provided	Not tested or not disclosed	Endotoxin contamination triggers inflammatory responses in cell culture and animal models, confounding mitochondrial function readouts
Lead Time	5–10 business days for small-batch synthesis on demand	Immediate shipping from inventory	On-demand synthesis ensures peptide is freshly prepared, reducing age-related degradation

When evaluating suppliers for first time buying SS-31, ask for three documents before placing an order: the HPLC chromatogram showing retention time and peak purity, the mass spectrometry report confirming sequence, and the endotoxin test result if your work involves biological systems. Suppliers who cannot or will not provide these documents are selling peptides suitable only for preliminary feasibility studies. Not for publication-quality mechanistic research. Real Peptides provides all three with every SS-31 order because our synthesis process is built around exact amino-acid sequencing and small-batch preparation. The same standards we apply to BPC-157 Peptide, Thymosin Alpha-1, and every compound in our full peptide collection.

What If: First Time Buying SS-31 Scenarios

What If My SS-31 Arrives Without Cold Packs or Shows Evidence of Thawing During Shipping?

Contact the supplier immediately and request temperature logging data or a replacement. Lyophilized SS-31 can tolerate brief temperature excursions, but if the package arrived warm or the peptide shows visible moisture inside the vial, oxidation has likely occurred. Do not reconstitute and assume it's functional. Oxidized SS-31 retains solubility and appears normal but loses cardiolipin binding affinity. Request a replacement shipment with verified cold-chain handling, and if the supplier cannot provide temperature logs, consider this a disqualifying failure for research-grade procurement. In our fulfillment process, every SS-31 shipment includes insulated packaging with temperature monitoring specifically to prevent this scenario. Peptides that experience thermal excursions during transit are replaced at no cost because we can verify shipping conditions through logged data.

What If My HPLC Chromatogram Shows a Purity of 96% — Is That Sufficient for Mechanistic Studies?

96% purity is acceptable for preliminary dose-finding or feasibility work, but insufficient for mechanistic studies where precise molar concentrations determine outcomes. The 4% impurity may include truncated peptides, oxidized analogs, or synthesis byproducts that don't interfere with solubility but contribute nothing to cardiolipin binding. For experiments measuring mitochondrial membrane potential, ROS production, or ATP synthesis as a function of SS-31 concentration, that 4% gap introduces a systematic error that scales with dose. If your supplier provides only 96% purity, calculate your working concentrations assuming 96% functional peptide rather than 100%, and document this adjustment in your methods. For dose-response studies or work intended for publication, request ≥98% purity and verify it with the provided chromatogram. Suppliers like Real Peptides targeting research-grade standards routinely achieve ≥98% for tetrapeptides like SS-31 through optimized synthesis and purification protocols.

What If I Need SS-31 for In Vivo Studies — Are There Additional Supplier Requirements?

Yes. Endotoxin testing and sterility verification become critical for in vivo applications. Lipopolysaccharide contamination from bacterial synthesis systems can trigger inflammatory responses, fever, and cytokine release independent of SS-31's mitochondrial effects, confounding any readout related to ischemia-reperfusion injury, neuroinflammation, or metabolic function. Request a Certificate of Analysis showing endotoxin content <1 EU/mg by LAL assay, and ensure the peptide was synthesized and lyophilized under aseptic conditions. For injectable studies, filter sterilize your reconstituted SS-31 through a 0.22 μm filter immediately before administration. If your protocol involves repeated dosing over days or weeks, prepare single-dose aliquots in sterile saline, freeze them at −80°C, and thaw one aliquot per injection to eliminate contamination risk from multi-draw vials stored at 4°C.

What If My Study Requires a Custom Concentration or Formulation of SS-31?

Most suppliers ship SS-31 as lyophilized powder in standard quantities (5mg, 10mg, 50mg), leaving reconstitution and formulation to the end user. If your experimental design requires pre-formulated SS-31 in a specific buffer, pH, or concentration. For example, for high-throughput screening or automated injection systems. Verify whether the supplier offers custom formulation services. Real Peptides synthesizes peptides on demand in small batches, which allows flexibility in final formulation if requested before synthesis. Custom requests add lead time (typically 10–14 business days instead of 5–7), but eliminate reconstitution variability and ensure your SS-31 arrives ready for immediate use in your experimental system. This approach is particularly valuable for multi-site studies where protocol standardization across labs is critical.

The Rigorous Truth About Research-Grade Peptide Procurement

Here's the honest answer: most peptide suppliers are selling compounds optimized for cost per milligram, not reproducibility per experiment. The difference between a $250 vial of SS-31 and a $400 vial isn't markup. It's the cost of HPLC purification to ≥98%, mass spectrometry sequence verification, endotoxin testing, and cold-chain logistics with temperature monitoring. Those steps don't change what the peptide looks like when it arrives. It's still a white lyophilized powder in a glass vial. But they determine whether the peptide works the same way in week 12 of your study as it did in week 1.

If you're running preliminary experiments to determine whether SS-31 is worth pursuing in your research model, 95% purity from a low-cost supplier is probably sufficient. But if you're running dose-response curves for publication, comparing SS-31 to other mitochondrial-targeting compounds, or integrating it into a multi-year translational research program, the 3–5% purity gap and lack of sequence verification will introduce variability you'll spend months troubleshooting. We've seen research teams repeat entire study cohorts because their peptide source changed suppliers mid-protocol and the new batch. Despite identical listed specifications. Produced different results. That doesn't happen when every batch comes with verified chromatograms and confirmed sequence data.

The bottom line: for first time buying SS-31, prioritize suppliers who treat peptide synthesis as precision chemistry, not bulk commodity production. Ask for the chromatogram, the mass spec report, and the cold-chain documentation. If the supplier can't provide them, or if the data shows purity below 98%, you're not saving money. You're transferring the cost of quality control from the supplier to your lab's time and your study's statistical power.

Peptide research depends on molecular precision. The tetrapeptide sequence that makes SS-31 effective is four amino acids long, and changing even one residue eliminates its therapeutic potential. That level of precision doesn't happen by accident, and it doesn't persist through careless handling. When you're evaluating suppliers for first time buying SS-31, you're not just choosing a vendor. You're choosing whether your study will produce reproducible mechanistic data or spend months chasing artifacts introduced during synthesis, storage, or shipping. Every peptide we synthesize at Real Peptides. Whether it's SS-31, Semax, or Selank. Follows the same quality standard: exact amino-acid sequencing, verified by chromatography and mass spectrometry, with cold-chain integrity from synthesis to your lab. That's not premium service. It's the baseline requirement for research-grade peptide procurement, and it's the standard that separates data you can publish from data you have to repeat.

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

SS-31 (Elamipretide) is an aromatic-cationic tetrapeptide with the sequence D-Arg-Dmt-Lys-Phe-NH2 that selectively binds to cardiolipin, a phospholipid found almost exclusively on the inner mitochondrial membrane. Its positively charged D-Arg residue and hydrophobic aromatic residues allow it to penetrate lipid bilayers and concentrate in mitochondria at ratios exceeding 5,000:1 relative to the cytosol. Once localized, SS-31 prevents cardiolipin peroxidation, stabilizes cristae structure, and maintains electron transport chain efficiency — reducing reactive oxygen species production and preserving ATP synthesis even under oxidative stress or ischemic conditions.

Research-grade SS-31 should be ≥98% pure as determined by analytical HPLC, with sequence confirmed by mass spectrometry. Purity below 98% means 2% or more of the material is truncated peptides, oxidized analogs, or synthesis byproducts that contribute nothing to cardiolipin binding — introducing systematic error in dose-response studies where precise molar concentrations determine outcomes. For preliminary feasibility work, 95–96% purity may be acceptable, but publication-quality mechanistic studies require ≥98% purity with documented chromatograms to ensure reproducibility across experimental replicates and study cohorts.

No — reconstituted SS-31 stored at 4°C shows measurable oxidation of the dimethyltyrosine (Dmt) residue within 7–10 days, which progressively reduces cardiolipin binding affinity even though the solution remains clear and soluble. For multi-week studies, prepare frozen aliquots in your final working concentration and store them at −80°C, where SS-31 maintains >95% purity for at least 6 months. Thaw one aliquot per experiment day rather than diluting repeatedly from a single refrigerated stock, as this approach eliminates freeze-thaw degradation and prevents cumulative oxidation that occurs in refrigerated aqueous solutions.

Cold-chain handling means the peptide is stored at −20°C from synthesis through shipping and delivered with insulated packaging and temperature monitoring to prevent thermal degradation. Lyophilized SS-31 exposed to temperatures above 25°C during shipping — even for 24–48 hours — undergoes accelerated oxidation of the Dmt residue and aggregation, effects that are invisible to visual inspection but eliminate mitochondrial targeting capacity. Suppliers using cold packs without temperature loggers cannot verify your shipment remained below the degradation threshold, which is why research-grade SS-31 requires documented cold-chain integrity, not just the presence of ice packs in the box.

SS-31 differs from MitoQ and SkQ1 in its mechanism of localization and molecular target. MitoQ and SkQ1 are lipophilic cations that accumulate in mitochondria driven by membrane potential and deliver antioxidant payloads (ubiquinone or plastoquinone), whereas SS-31 targets cardiolipin directly through electrostatic and hydrophobic interactions independent of membrane potential. This means SS-31 retains mitochondrial localization even in depolarized or damaged mitochondria where MitoQ accumulation would be reduced. Functionally, SS-31 stabilizes cristae architecture and prevents cytochrome c release, while MitoQ primarily scavenges reactive oxygen species — making them complementary rather than interchangeable for different experimental models.

Contact the supplier immediately and request the missing documentation before reconstituting the peptide. HPLC chromatograms verify purity and identify impurity peaks, while mass spectrometry confirms the peptide sequence matches D-Arg-Dmt-Lys-Phe-NH2 exactly — both are essential for research-grade procurement. Suppliers who cannot provide these documents are selling peptides that meet only minimum commercial standards, not the specifications required for mechanistic studies where sequence fidelity and structural integrity determine outcomes. If the supplier refuses or cannot provide the data, consider this a disqualifying failure and source your SS-31 from a research-grade supplier who includes verified analytical data with every batch.

SS-31 is highly suitable for cell culture experiments studying mitochondrial dysfunction, oxidative stress, ischemia-reperfusion injury models, and apoptosis pathways. Its ability to penetrate cell membranes and concentrate in mitochondria without requiring transfection or specialized delivery systems makes it ideal for in vitro mechanistic work. For cell culture applications, ensure your SS-31 has endotoxin content <1 EU/mg to prevent lipopolysaccharide-induced inflammatory responses that would confound mitochondrial function readouts, and filter sterilize reconstituted solutions through a 0.22 μm filter before adding to culture media. Typical working concentrations in cell culture range from 1–50 μM depending on the model and endpoint measured.

Degraded SS-31 retains solubility and appears visually normal but loses cardiolipin binding affinity due to oxidation of the dimethyltyrosine residue or aggregation from repeated freeze-thaw cycles. In experimental systems, this manifests as null results or inconsistent dose-response relationships — the peptide is present at the calculated concentration but functionally inactive. There is no simple way to test for degradation without re-running HPLC analysis, which is why prevention through proper storage (−80°C for aliquots, −20°C for lyophilized powder) and cold-chain shipping is critical. If you suspect degradation, do not attempt to salvage the batch — request replacement from the supplier and document the storage or handling failure that caused the issue.

The D-Arg (D-arginine) residue at the N-terminus of SS-31 provides resistance to proteolytic degradation by aminopeptidases, which specifically cleave L-amino acids but cannot process D-amino acid residues efficiently. This modification extends SS-31’s half-life in biological systems and maintains its structural integrity long enough to reach and bind cardiolipin in mitochondria. If L-arginine were used instead, the tetrapeptide would be rapidly degraded by proteases in serum, cell culture media, or tissue homogenates — eliminating its therapeutic or research effect before mitochondrial localization could occur. This is why sequence verification by mass spectrometry is essential for first time buying SS-31, as synthesis errors substituting L-Arg for D-Arg produce a peptide with similar molecular weight but no functional stability.

Most research-grade SS-31 is supplied as lyophilized powder because this form provides maximum stability during storage and shipping, with shelf life exceeding 12 months at −20°C. Pre-made aqueous solutions are uncommon because reconstituted SS-31 begins oxidizing within 7–10 days at 4°C, making long-term storage impractical. Some suppliers offer custom formulation services where SS-31 is reconstituted in specific buffers, pH, or concentrations immediately before shipping for time-sensitive experiments or high-throughput applications. If your experimental design requires pre-formulated SS-31, verify whether the supplier offers this service and confirm the solution will be prepared fresh within 48 hours of shipment — not drawn from pre-made inventory that has been stored for weeks.

Yes, SS-31 and Elamipretide refer to the same compound — the aromatic-cationic tetrapeptide with sequence D-Arg-Dmt-Lys-Phe-NH2. SS-31 is the research designation used in preclinical studies, while Elamipretide is the International Nonproprietary Name (INN) assigned for clinical development. The compound has also been referred to as Bendavia or MTP-131 in earlier literature. All four names describe the identical molecule with the same mitochondrial-targeting mechanism and cardiolipin binding properties, so when sourcing the peptide for research, verify the sequence rather than relying solely on the name to ensure you receive the correct compound.

Sterile water is sufficient for reconstituting SS-31 if you plan to aliquot and freeze the solution immediately or use it within 24–48 hours. Bacteriostatic water, which contains 0.9% benzyl alcohol as a preservative, extends the shelf life of reconstituted peptides stored at 4°C by preventing bacterial growth — but it does not prevent oxidation of the Dmt residue, which is the primary degradation pathway for SS-31 in aqueous solution. For short-term use or single-dose applications, sterile water or phosphate-buffered saline at pH 7.0–7.4 is preferred. For multi-draw vials that will be stored refrigerated and used over several days, bacteriostatic water reduces contamination risk, but the solution should still be used within 7–10 days before oxidation reduces functional activity.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA